|
|
|
|
|
|||||||
|
Session 85
Poster Session
HCV Co-Infection: Diagnosis and Pathogenesis 4:30-6:30 pm 4E-F |
to view the poster for an abstract.| 642-M. | Comparative Sensitivity of HCV Antibody vs Qualitative RNA in Screening for HCV in HIV-Infected Patients M. Carten*1, O. Falusi1, 2, A. Truckenbrod1, R. Lollar1, M. K. Hayden1, and H. Kessler1 1Rush Med. Coll. and 2Cook County Hosp., Chicago, IL
| ||
| 643-M. | Comparative Analysis of HCV RNA in Serum, Liver, and Peripheral Blood Mononuclear Cells (PBMC) in Patients with HIV Infection vs Patients with HIV and HCV Co-Infection M. Furione*, M. Gatti, F. Baldanti, G. Piccinini, R. Maserati, R. Bruno, and G. Gerna IRCCS PoliClin., San Matteo, Univ. degli Studi, Pavia, Italy
| ||
| 644-M. | Does CCR2b-V64I Influence HCV and HCV/HIV Co-Infection? G. Ahlenstiel*, R. P. Woitas, J. K. Rockstroh, H. H. Brackmann, B. Kupfer, T. Sauerbruch, and U. Spengler Univ. of Bonn, Germany
| ||
| 645-M. | HIV env Mediates Apoptosis of Human Hepatocytes via CXCR4 S. Vlahakis*, A. Villasis-Keever, T. Gomez, and C. V. Paya Mayo Clin., Rochester, MN
| ||
| 646-M. | Factors Associated with Liver Fibrosis in HIV-1 HCV Co-Infected Patients on Antiretroviral Therapy D. Fuster*, C. Tural, J. Tor, J. Romeu, I. Ojanguren, G. Sirera, R. Muga, Á. Ballesteros, E. Negredo, H. Guardiola, R. Planas, C. Rey-Joly, and B. Clotet Univ. Autònoma de Barcelona, Spain
| ||
| 647-M. | Serum Biochemical Markers of Liver Fibrosis in HIV and HCV Co-Infected Patients Y. Benhamou*, R. P. Myers, M. Bochet, F. Imbert-Bismut, V. Thibault, C. Katlama, and T. Poynard for the MULTIVIRC Group Groupe Hosp. Pitié-Salpêtrière, Paris, France
| ||
| 648-M. | Presence of HCV RNA in Cervico-Vaginal Lavages Obtained from HIV-1/HCV Co-Infected Women M. Nowicki*1, T. Laskus2, M. Radkowski2, J. Rakela2, and A. Kovacs1 1Univ. of Southern California, Los Angeles and 2Mayo Clin., Scottsdale, AZ
| ||
| 649-M. | Hepatitis C Virus Replication in the Central Nervous System T. Laskus1, M. Radkowski2, J. Wilkinson1, A. Bednarska2, M. Nowicki3, and J. Rakela1 1 Mayo Clin., Scottsdale, AZ; 2Inst. of Infectious Diseases, Warsaw, Poland; and 3Univ. of Southern California, Los Angeles
|
